Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018636HBVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS10052391HBVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30006267HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30078147HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30086949HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30034236HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30034237HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30034238HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30034239HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TVIS30034240HIVENSG00000122966.18protein_codingCITNoNo11113O14578
TCGA Plot Options
Drug Information
GeneCIT
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009424
UniProt IDO14578
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830